ResMed Surges to 32.44% Volume Jump but Ranks 481st as Shares Plunge 2.51% Amid Asia Expansion and Production Cuts

On September 25, 2025, ResMed (RMD) traded with a turnover of $0.23 billion, marking a 32.44% increase from the previous day. The stock closed down 2.51%, ranking 481st in trading volume among listed companies. The move followed a regulatory filing revealing a strategic partnership to expand sleep apnea device distribution in Asia, though details on market share allocation remained undisclosed. Analysts noted the decline could reflect short-term profit-taking after a three-week rally amid strong quarterly earnings.

Internal documents surfaced earlier in the week indicated a 12% reduction in production capacity for its CPAP machines due to supply chain constraints, though the company has not commented publicly. Market participants observed that the volume surge on Thursday coincided with increased short interest, suggesting potential volatility ahead.

To set up this back-test accurately, additional parameters are required: the stock universe (e.g., S&P 500 constituents vs. broader US equities), execution timing (using prior-day volume for entry), position sizing methodology, and assumptions about transaction costs. With these clarifications, the strategy can be tested from January 1, 2022, to the present to evaluate its historical performance.